Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q3 2021 Earnings

29OctExpected
Q2 2021
Q3 2021
0.05
0.07
0.09
0.11

Details

Expected EPS
N/A
Actual EPS
0.11
Surprise EPS
0.11
Surprise Percent
+∞%

Description

Chengdu Olymvax Biopharmaceuticals (688319.SHG) has reported earnings of 0.11 per share for Q3 2021.

0 Comments

Share your thoughts